Variables | Patients with PC (n = 128) | Patient without PC (n = 226) | All patients (n = 354) |
---|---|---|---|
Age (y/o)a | 63.0 ± 9.5 | 62.4 ± 10.8 | 62.6 ± 10.3 |
Gender (male:female) | 96: 32 | 148: 78 | 244: 1110 |
Body mass index (kg/m2)a | 22.4 ± 3.4 | 21.9 ± 3.1 | 22.1 ± 3.2 |
Comorbidity: n (%) | 63 (49.2) | 111 (49.1) | 174 (49.2) |
Prior operations: n (%) | 14 (10.9) | 32 (14.2) | 46 (13.0) |
ASA: n (%) | |||
Class 1 | 62 (48.4) | 110 (48.7) | 172 (48.6) |
Class 2 | 50 (39.1) | 96 (42.5) | 146 (41.2) |
Class 3 | 16 (12.5) | 20 (8.8) | 36 (10.2) |
Tumor size (mm)a | 48.0 ± 33.0 | 39.3 ± 24.4 | 42.4 ± 28.1 |
Type of resection: n (%) | |||
LDG | 74 (57.8) | 177 (78.3) | 251 (70.9) |
LTG | 54 (42.2) | 49 (21.7) | 103 (29.1) |
Harvested lymph nodes (n)a | 43.8 ± 15.3 | 44.6 ± 15.9 | 44.3 ± 15.7 |
Pathological status (yp/p): n (%) | |||
CR | 8 (6.3) | 0 (0) | 8 (2.3) |
T1 | 24 (18.8) | 100 (44.2) | 124 (35.1) |
T2 | 19 (14.8) | 40 (17.7) | 59 (16.7) |
T3 | 36 (28.1) | 27 (11.9) | 63 (17.8) |
T4 | 41 (32.0) | 59 (26.1) | 100 (28.2) |
Lymph node metastasis (yp/p): n (%) | |||
N0 | 70 (54.7) | 130 (57.5) | 200 (56.5) |
N1 | 20 (15.6) | 39 (17.3) | 59 (16.7) |
N2 | 20 (15.6) | 35 (15.5) | 55 (15.5) |
N3 | 18 (14.1) | 22 (9.7) | 40 (11.3) |
Stage (yp/p): n (%) | |||
CR | 8 (6.3) | 0 (0) | 8 (2.3) |
Stage I | 36 (28.1) | 113 (50.0) | 149 (42.1) |
Stage II | 43 (33.6) | 58 (25.7) | 101 (28.5) |
Stage III | 41 (32.0) | 55 (24.3) | 96 (27.1) |
Median follow-up period (month) | 40.9 | 45.4 | 43.8 |